Key result
Transcatheter ASD closure yields zero deaths or erosions, but complications rise in children ≤15 kg.
Why the study?
What are the procedural characteristics, early clinical outcomes, and long-term complications of transcatheter ASD closure using Amplatzer Septal Occluder in children?
Cohort (n=1,326)
Yes
What are the procedural characteristics, early clinical outcomes, and long-term complications of transcatheter ASD closure using Amplatzer Septal Occluder in children?
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“This guidance is not meant to replace health care providers' clinical judgment but rather to improve the value of care by reducing practice variation and optimizing resource utilization.”
Transcatheter ASD closure using the Amplatzer Septal Occluder is safe and effective in children, with excellent long-term outcomes and no cardiac erosions, though smaller children and those with large defects face higher complication risks.
No abstract yet. The journal hasn't published one we can show.
Journal, society, and media accounts. Useful signal, not independent expert judgment.
No takes yet. Share an insight, caveat, or question.
Jalal et al. (2018) conducted a cohort in Atrial septal defect (ASD) (n=1,326). Transcatheter ASD closure with Amplatzer Septal Occluder was evaluated on Procedural characteristics, early clinical outcome, and long-term complications. Transcatheter ASD closure using the Amplatzer Septal Occluder in 1,326 children resulted in 0 deaths or cardiac erosions, though complication risk was greater in children ≤15 kg or with large ASDs.
Synapse has enriched 10 related papers. Consider them for comparative context: